MRMark RatainMDSlidesetInternational Workshop on Dose Optimization Strategies for Targeted Drugs – Focus on Oncolytics 2015Pharmacology as a tool to dose individualize [...] - Mark Ratain, MDView Slideset
SlidesetInternational Workshop on Dose Optimization Strategies for Targeted Drugs – Focus on Oncolytics 2015Is cancer different - George Demetri, MDView Slideset
SlidesetInternational Workshop on Dose Optimization Strategies for Targeted Drugs – Focus on Oncolytics 2015Optimal TDM and pharmacodynamics of mitotane - S. AcklandView Slideset
SlidesetInternational Workshop on Dose Optimization Strategies for Targeted Drugs – Focus on Oncolytics 2015Obstacles to use dose optimization in an [...] - Rene Bruno, PhDView Slideset
SlidesetInternational Workshop on Dose Optimization Strategies for Targeted Drugs – Focus on Oncolytics 2015Modeling as a tool to individualize - Joga Gobburu, PhD, MBAView Slideset
SlidesetInternational Workshop on Dose Optimization Strategies for Targeted Drugs – Focus on Oncolytics 2015Microdosing as a pharmacokinetic assessment tool - W. VaesView Slideset
SlidesetInternational Workshop on Dose Optimization Strategies for Targeted Drugs – Focus on Oncolytics 2015Marker of bevacizumab efficacy - C. SerdjebiView Slideset
SlidesetInternational Workshop on Dose Optimization Strategies for Targeted Drugs – Focus on Oncolytics 2015Everolimus exposure strongly related to dose [...]-D. De WitView Slideset
CFCourtney FletcherPharmDSlidesetInternational Workshop on Dose Optimization Strategies for Targeted Drugs – Focus on Oncolytics 2015Dose Individualization in H[...] - Courtney Fletches, PharmDView Slideset
SlidesetInternational Workshop on Dose Optimization Strategies for Targeted Drugs – Focus on Oncolytics 2015Drug-drug interactions in patients ... - R. van LeeuwenView Slideset
SlidesetInternational Workshop on Dose Optimization Strategies for Targeted Drugs – Focus on Oncolytics 2015Dried blood spot sampling for therapeutic drug - D. De WitView Slideset
SlidesetInternational Workshop on Dose Optimization Strategies for Targeted Drugs – Focus on Oncolytics 2015Toxicity-adjusted dose (TAD) of sunitinib - H. GurneyView Slideset
